|
Agreement adds new analyzer platforms and expands assay menu across key international markets
SAN DIEGO, Feb. 16, 2026 /PRNewswire/ -- QuidelOrtho has entered a long-term strategic supply agreement with Lifotronic Technology Co., Ltd. (Lifotronic Technology Co., Ltd., stock code: 688389), to expand QuidelOrtho's global immunoassay portfolio and accelerate customer access to scalable, high quality, cost-efficient solutions across select markets outside the United States.
The agreement provides QuidelOrtho access to multiple high-throughput and low-to-mid volume immunoassay analyzer platforms, each supported by a broad menu of assays spanning routine and specialty testing. The collaboration is expected to expand QuidelOrtho's immunoassay menu with more than 25 new assays on these systems that are not currently available on the VITROS system, within a total menu of over 70 assays on these new partner platforms.
These additions are planned to increase QuidelOrtho's ability to compete for full-menu tenders and serve a wider range of laboratory settings, from smaller laboratories seeking low-volume solutions to larger, high-throughput environments that require scalable capacity and broad test menus.
Bryan Hanson, Senior Vice President of Global Clinical Laboratory and Transfusion Medicine at QuidelOrtho, said:
"Through our collaboration with Lifotronic Technology, QuidelOrtho will rapidly introduce scalable testing solutions that further advance our long-term innovation strategy in core growth markets. This agreement strengthens our portfolio in markets where assay breadth and cost efficiency are key requirements, while offering customers a broader and more diverse set of solutions."
Mr. Liu Xiancheng, Chairman of Lifotronic Technology, said:
"This strategic partnership with QuidelOrtho marks an important milestone in Lifotronic Technology's global expansion strategy. Going forward, we will work closely with QuidelOrtho, continuing to leverage our in-house R&D strengths to deliver high-value diagnostic solutions that meet real clinical needs for customers worldwide."
The commercial focus will be on Europe, the Middle East, Africa, Mexico, Central America, South America, India, China, Japan, and Asia-Pacific regions. This strategic expansion is planned to support QuidelOrtho's ability to address menu gaps, increase competitiveness in international tenders, and deliver more complete immunoassay solutions to laboratories seeking broader menus and flexible system options.
Source: QuidelOrtho Corporation
About QuidelOrtho
QuidelOrtho (Nasdaq: QDEL) is a global leader in diagnostic solutions, with expertise in clinical chemistry, immunoassay, immunohematology, and molecular diagnostics. The company is dedicated to delivering fast, accurate, and reliable test results to help improve patient outcomes across settings ranging from point-of-care to hospitals, laboratories, and clinics. Building on a strong legacy of innovation, QuidelOrtho partners with healthcare providers to advance diagnostic technologies, connecting insights with solutions to enable informed decision-making and better healthcare delivery.
About Lifotronic Technology
Shenzhen Lifotronic Technology Co., Ltd. (stock code: 688389) is a high-tech medical device company driven by both R&D and commercialization, recognized as a National High-Tech Enterprise and a "Specialized and Innovative Little Giant" enterprise in China. The company focuses on two major business areas: in vitro diagnostics, and therapy and rehabilitation, and is committed to providing innovative, reliable, and cost-effective medical products and solutions to healthcare institutions worldwide. In the IVD field, Lifotronic Technology has built a comprehensive product portfolio covering electrochemiluminescence, HbA1c, and specific protein technologies. In electrochemiluminescence, the company has achieved a full lineup of low-, mid-, and high-throughput immunoassay instruments and reagents. Its products have obtained international certifications such as CE and are distributed globally, continuing to advance precision medicine and global health through technological innovation.
The products referenced in this press release are not currently planned for sale in the United States. These products have not received approval, clearance, or authorization for marketing in any jurisdiction, including the United States, and are not currently marketed or sold. Product launch, sale, and use are subject to obtaining the required regulatory approvals, clearances, or authorizations in each jurisdiction, and there can be no assurance that such approvals will be obtained or obtained within a specific timeframe. Statements regarding future product availability, features, performance, or timing are based on current expectations and are subject to change.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are any statement contained herein that is not strictly historical, including, but not limited to, those relating to the agreement entered into by and between QuidelOrtho and Lifotronic and the transactions contemplated therein, and other future plans, objectives, strategies, expectations and intentions. Such statements are based on the beliefs and expectations of QuidelOrtho's management as of the date of this press release and are subject to significant known and unknown risks and uncertainties. Actual results or outcomes may differ significantly from those set forth or implied in the forward-looking statements. Factors, including those discussed under Part I, Item 1A, "Risk Factors" of QuidelOrtho's Annual Report on Form 10-K for the fiscal year ended December 29, 2024 and subsequent reports filed with the Securities and Exchange Commission, among others, could cause actual results to differ from those set forth or implied in the forward-looking statements. You should not rely on forward-looking statements as predictions of future events because these statements are based on assumptions that may not come true and are speculative by their nature. All forward-looking statements are based on information currently available to QuidelOrtho and speak only as of the date of this press release. QuidelOrtho undertakes no obligation to update any of the forward-looking information or time-sensitive information included in this press release, whether as a result of new information, future events, changed expectations or otherwise, except as required by law.
Investor Contact:
Juliet Cunningham
Vice President, Investor Relations
IR@QuidelOrtho.com
Media Contact:
D. Nikki Wheeler
Senior Director, Corporate Communications
media@QuidelOrtho.com
Agreement adds new analyzer platforms and expands assay menu across key international markets
SAN DIEGO, Feb. 16, 2026 /PRNewswire/ -- QuidelOrtho has entered a long-term strategic supply agreement with Lifotronic Technology Co., Ltd. (Lifotronic Technology Co., Ltd., stock code: 688389), to expand QuidelOrtho's global immunoassay portfolio and accelerate customer access to scalable, high quality, cost-efficient solutions across select markets outside the United States.
The agreement provides QuidelOrtho access to multiple high-throughput and low-to-mid volume immunoassay analyzer platforms, each supported by a broad menu of assays spanning routine and specialty testing. The collaboration is expected to expand QuidelOrtho's immunoassay menu with more than 25 new assays on these systems that are not currently available on the VITROS system, within a total menu of over 70 assays on these new partner platforms.
These additions are planned to increase QuidelOrtho's ability to compete for full-menu tenders and serve a wider range of laboratory settings, from smaller laboratories seeking low-volume solutions to larger, high-throughput environments that require scalable capacity and broad test menus.
Bryan Hanson, Senior Vice President of Global Clinical Laboratory and Transfusion Medicine at QuidelOrtho, said:
"Through our collaboration with Lifotronic Technology, QuidelOrtho will rapidly introduce scalable testing solutions that further advance our long-term innovation strategy in core growth markets. This agreement strengthens our portfolio in markets where assay breadth and cost efficiency are key requirements, while offering customers a broader and more diverse set of solutions."
Mr. Liu Xiancheng, Chairman of Lifotronic Technology, said:
"This strategic partnership with QuidelOrtho marks an important milestone in Lifotronic Technology's global expansion strategy. Going forward, we will work closely with QuidelOrtho, continuing to leverage our in-house R&D strengths to deliver high-value diagnostic solutions that meet real clinical needs for customers worldwide."
The commercial focus will be on Europe, the Middle East, Africa, Mexico, Central America, South America, India, China, Japan, and Asia-Pacific regions. This strategic expansion is planned to support QuidelOrtho's ability to address menu gaps, increase competitiveness in international tenders, and deliver more complete immunoassay solutions to laboratories seeking broader menus and flexible system options.
Source: QuidelOrtho Corporation
About QuidelOrtho
QuidelOrtho (Nasdaq: QDEL) is a global leader in diagnostic solutions, with expertise in clinical chemistry, immunoassay, immunohematology, and molecular diagnostics. The company is dedicated to delivering fast, accurate, and reliable test results to help improve patient outcomes across settings ranging from point-of-care to hospitals, laboratories, and clinics. Building on a strong legacy of innovation, QuidelOrtho partners with healthcare providers to advance diagnostic technologies, connecting insights with solutions to enable informed decision-making and better healthcare delivery.
About Lifotronic Technology
Shenzhen Lifotronic Technology Co., Ltd. (stock code: 688389) is a high-tech medical device company driven by both R&D and commercialization, recognized as a National High-Tech Enterprise and a "Specialized and Innovative Little Giant" enterprise in China. The company focuses on two major business areas: in vitro diagnostics, and therapy and rehabilitation, and is committed to providing innovative, reliable, and cost-effective medical products and solutions to healthcare institutions worldwide. In the IVD field, Lifotronic Technology has built a comprehensive product portfolio covering electrochemiluminescence, HbA1c, and specific protein technologies. In electrochemiluminescence, the company has achieved a full lineup of low-, mid-, and high-throughput immunoassay instruments and reagents. Its products have obtained international certifications such as CE and are distributed globally, continuing to advance precision medicine and global health through technological innovation.
The products referenced in this press release are not currently planned for sale in the United States. These products have not received approval, clearance, or authorization for marketing in any jurisdiction, including the United States, and are not currently marketed or sold. Product launch, sale, and use are subject to obtaining the required regulatory approvals, clearances, or authorizations in each jurisdiction, and there can be no assurance that such approvals will be obtained or obtained within a specific timeframe. Statements regarding future product availability, features, performance, or timing are based on current expectations and are subject to change.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are any statement contained herein that is not strictly historical, including, but not limited to, those relating to the agreement entered into by and between QuidelOrtho and Lifotronic and the transactions contemplated therein, and other future plans, objectives, strategies, expectations and intentions. Such statements are based on the beliefs and expectations of QuidelOrtho's management as of the date of this press release and are subject to significant known and unknown risks and uncertainties. Actual results or outcomes may differ significantly from those set forth or implied in the forward-looking statements. Factors, including those discussed under Part I, Item 1A, "Risk Factors" of QuidelOrtho's Annual Report on Form 10-K for the fiscal year ended December 29, 2024 and subsequent reports filed with the Securities and Exchange Commission, among others, could cause actual results to differ from those set forth or implied in the forward-looking statements. You should not rely on forward-looking statements as predictions of future events because these statements are based on assumptions that may not come true and are speculative by their nature. All forward-looking statements are based on information currently available to QuidelOrtho and speak only as of the date of this press release. QuidelOrtho undertakes no obligation to update any of the forward-looking information or time-sensitive information included in this press release, whether as a result of new information, future events, changed expectations or otherwise, except as required by law.
Investor Contact:
Juliet Cunningham
Vice President, Investor Relations
IR@QuidelOrtho.com
Media Contact:
D. Nikki Wheeler
Senior Director, Corporate Communications
media@QuidelOrtho.com
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
QuidelOrtho Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio
QuidelOrtho Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio
QuidelOrtho Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio
|
Plume Platform powers smarter, more consistent in-home Wi-Fi experiences across FPT subscriber base.
HANOI, Vietnam and PALO ALTO, Calif., March 18, 2026 /PRNewswire/ -- FPT Telecom, one of Vietnam's leading telecommunications and Internet service providers and a subsidiary of FPT Corporation, today announced a strategic partnership with personalized smart services pioneer Plume® to bring the globally recognized Plume Platform to FPT Telecom subscribers across Vietnam. The deployment marks a significant step in FPT Telecom's ongoing commitment to delivering the best possible in-home connectivity experience for its customers.
FPT's network leverages the Plume Platform's advanced Wi-Fi optimization and AI-informed application recognition and prioritization technologies to create a more consistent, reliable home network that adapts to the way each household uses the Internet. Whether subscribers are streaming video, joining video calls, gaming or working from home, the Plume Platform intelligently identifies and prioritizes the applications and activities that matter most, ensuring smoother performance across every connected device. Powered by cloud-based analytics and AI/machine learning, Plume continuously improves performance by learning from patterns across tens of millions of households globally, helping the network adapt to new devices and applications over time.
"Our mission at Plume is to help the world's best internet service providers deliver the best customer experience possible," said Dan Herscovici, President and CEO of Plume. "FPT's commitment to putting the customer experience first aligns perfectly with what Plume does every day for ISPs around the world, and we look forward to helping them deliver a network experience that truly reflects that commitment, powered by Wi-Fi-optimization and AI-informed application prioritization capabilities to subscribers across Vietnam."
Today's households rely on Wi-Fi for an ever-growing range of activities, from remote work and online education to high-definition streaming and smart home devices. Delivering consistent, high-performance connectivity across every corner of the home is no longer a nice-to-have; it is essential. By selecting Plume as a technology partner, FPT is taking a proactive step to meet that demand and raise the bar for the subscriber experience in Vietnam.
"At FPT, improving customer experience is always our top priority," said Mr. Le Trung, Director of Infrastructure Development and Management Center, FPT Telecom, FPT Corporation. "We are a technology pioneer in Vietnam and among the first to widely deploy Wi-Fi 6 and Wi-Fi 7, as well as introduce broadband services of up to 10Gbps. Building on this foundation, we continuously collaborate with leading technology partners to further enhance the quality and consistency of in-home Wi-Fi, enabling our subscribers to enjoy seamless, best-in-class connectivity for their everyday digital needs."
The Plume Platform on the FPT network delivers several AI-driven Wi-Fi optimization and security benefits to subscribers including:
- Intelligent Wi-Fi optimization that continuously adapts the home network to improve speed, coverage and reliability for every connected device.
- AI-informed application recognition and prioritization that identifies the apps and activities subscribers care most about — such as streaming, video calls and gaming — and ensures they perform at their best.
- A more consistent connectivity experience across the home, reducing buffering, lag and the frustrations that come with a poorly performing network.
- Advanced in-home security that helps protect every connected device—blocking malicious destinations and supporting capabilities like intrusion detection, IoT anomaly detection and device quarantine.
Through this partnership, FPT and Plume are working together to set a new standard for in-home Wi-Fi in Vietnam, one that places the needs and daily digital habits of subscribers at the center of everything while building trust.
About FPT Telecom
FPT Telecom Joint Stock Company is one of Vietnam's leading telecommunications and Internet service providers, and a member company of FPT Corporation — the largest IT corporation in Vietnam. Established in 1997, FPT Telecom was a pioneer in bringing Internet connectivity to Vietnamese citizens and continues to serve millions of households and businesses nationwide. Its services span broadband Internet (including fiber-to-the-home), IPTV, data center, cloud computing, and value-added digital services. FPT Telecom is guided by a customer-first philosophy and a continuous commitment to deploying state-of-the-art technology to deliver outstanding digital experiences. Learn more at https://www.fpt.vn.
About Plume
Plume created the first managed Wi-Fi platform for Internet Service Providers (ISPs) in 2016 and continues to lead today with a best-in-class solution for cloud-managed Wi-Fi, security, and workflow orchestration – all powered by an unmatched dataset and AI. With almost half a billion devices connected to its platform, Plume is a trusted technology partner for more than 400 ISPs around the world, helping them deliver subscriber confidence through better Wi-Fi experiences, new services, and proactive customer care. Plume leverages OpenSync®, an open-source framework that comes pre-integrated and supported on the leading silicon, CPE, and platform SDKs, and supports leading industry standards like RDK-B and prplWave. Combined with powerful AI orchestration tools with its acquisition of Sweepr, Plume now offers ISPs a true end-to-end solution to power their most important workflows and customer experiences, while making deployment simpler and faster. Plume is leading the way in providing ISPs an intelligence and innovation edge to stay competitive, build subscriber confidence, and adapt to the changing needs of the market. Discover more about how Plume is empowering ISPs by visiting https://www.plume.com.
Plume Platform powers smarter, more consistent in-home Wi-Fi experiences across FPT subscriber base.
HANOI, Vietnam and PALO ALTO, Calif., March 18, 2026 /PRNewswire/ -- FPT Telecom, one of Vietnam's leading telecommunications and Internet service providers and a subsidiary of FPT Corporation, today announced a strategic partnership with personalized smart services pioneer Plume® to bring the globally recognized Plume Platform to FPT Telecom subscribers across Vietnam. The deployment marks a significant step in FPT Telecom's ongoing commitment to delivering the best possible in-home connectivity experience for its customers.
FPT's network leverages the Plume Platform's advanced Wi-Fi optimization and AI-informed application recognition and prioritization technologies to create a more consistent, reliable home network that adapts to the way each household uses the Internet. Whether subscribers are streaming video, joining video calls, gaming or working from home, the Plume Platform intelligently identifies and prioritizes the applications and activities that matter most, ensuring smoother performance across every connected device. Powered by cloud-based analytics and AI/machine learning, Plume continuously improves performance by learning from patterns across tens of millions of households globally, helping the network adapt to new devices and applications over time.
"Our mission at Plume is to help the world's best internet service providers deliver the best customer experience possible," said Dan Herscovici, President and CEO of Plume. "FPT's commitment to putting the customer experience first aligns perfectly with what Plume does every day for ISPs around the world, and we look forward to helping them deliver a network experience that truly reflects that commitment, powered by Wi-Fi-optimization and AI-informed application prioritization capabilities to subscribers across Vietnam."
Today's households rely on Wi-Fi for an ever-growing range of activities, from remote work and online education to high-definition streaming and smart home devices. Delivering consistent, high-performance connectivity across every corner of the home is no longer a nice-to-have; it is essential. By selecting Plume as a technology partner, FPT is taking a proactive step to meet that demand and raise the bar for the subscriber experience in Vietnam.
"At FPT, improving customer experience is always our top priority," said Mr. Le Trung, Director of Infrastructure Development and Management Center, FPT Telecom, FPT Corporation. "We are a technology pioneer in Vietnam and among the first to widely deploy Wi-Fi 6 and Wi-Fi 7, as well as introduce broadband services of up to 10Gbps. Building on this foundation, we continuously collaborate with leading technology partners to further enhance the quality and consistency of in-home Wi-Fi, enabling our subscribers to enjoy seamless, best-in-class connectivity for their everyday digital needs."
The Plume Platform on the FPT network delivers several AI-driven Wi-Fi optimization and security benefits to subscribers including:
- Intelligent Wi-Fi optimization that continuously adapts the home network to improve speed, coverage and reliability for every connected device.
- AI-informed application recognition and prioritization that identifies the apps and activities subscribers care most about — such as streaming, video calls and gaming — and ensures they perform at their best.
- A more consistent connectivity experience across the home, reducing buffering, lag and the frustrations that come with a poorly performing network.
- Advanced in-home security that helps protect every connected device—blocking malicious destinations and supporting capabilities like intrusion detection, IoT anomaly detection and device quarantine.
Through this partnership, FPT and Plume are working together to set a new standard for in-home Wi-Fi in Vietnam, one that places the needs and daily digital habits of subscribers at the center of everything while building trust.
About FPT Telecom
FPT Telecom Joint Stock Company is one of Vietnam's leading telecommunications and Internet service providers, and a member company of FPT Corporation — the largest IT corporation in Vietnam. Established in 1997, FPT Telecom was a pioneer in bringing Internet connectivity to Vietnamese citizens and continues to serve millions of households and businesses nationwide. Its services span broadband Internet (including fiber-to-the-home), IPTV, data center, cloud computing, and value-added digital services. FPT Telecom is guided by a customer-first philosophy and a continuous commitment to deploying state-of-the-art technology to deliver outstanding digital experiences. Learn more at https://www.fpt.vn.
About Plume
Plume created the first managed Wi-Fi platform for Internet Service Providers (ISPs) in 2016 and continues to lead today with a best-in-class solution for cloud-managed Wi-Fi, security, and workflow orchestration – all powered by an unmatched dataset and AI. With almost half a billion devices connected to its platform, Plume is a trusted technology partner for more than 400 ISPs around the world, helping them deliver subscriber confidence through better Wi-Fi experiences, new services, and proactive customer care. Plume leverages OpenSync®, an open-source framework that comes pre-integrated and supported on the leading silicon, CPE, and platform SDKs, and supports leading industry standards like RDK-B and prplWave. Combined with powerful AI orchestration tools with its acquisition of Sweepr, Plume now offers ISPs a true end-to-end solution to power their most important workflows and customer experiences, while making deployment simpler and faster. Plume is leading the way in providing ISPs an intelligence and innovation edge to stay competitive, build subscriber confidence, and adapt to the changing needs of the market. Discover more about how Plume is empowering ISPs by visiting https://www.plume.com.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
FPT Partners with Plume to Deliver Intelligent Wi-Fi Optimization and Enhanced Connectivity for Vietnamese Households
